跳至主要内容
临床试验/CTRI/2020/05/025009
CTRI/2020/05/025009已完成4 期

To Evaluate the â??Real Worldâ?? CliNicalPerformAnce of the Bisoprolol in Post-myoCardialInfarcTion with Left Ventricular dYsfunction - TENACITY

Dr Kamal Sharma0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Post MI (NSTEMI & STEMI) patients with systolic LV dysfunction (HFmEF&HFrEF i.e. LVEF < 50%)
  • Patients prescribed with oral Bisoprolol (Concor) during or on discharge from the index hospitalization between 1st August 2016 to 30th November 2018 and follow-up data for up to 1 year from date of discharge and initiation of treatment under consideration, is available
  • Consent for data collection

排除标准

  • Age <18 at hospitalization
  • Patients with Beta Blocker other than bisoprolol at the index date
  • Patients who leave against medical advice during the hospitalization for MIwith incomplete revascularization.
  • Patients who die during hospitalization for MI
  • Patients presenting with high grade II degree and III degree AV block at the index date (contra-indication to beta-blockers)

研究者

发起方
Dr Kamal Sharma

相似试验